Sarepta Therapeutics Inc (NASDAQ:SRPT)
| 137.89 Delayed Data As of Mar 31 |  +1.86 / +1.37%Today’s Change | 61.28 Today|||52-Week Range 159.84 | +6.41% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Chambers Michael /aldevron/ Director |  Buy | 8/19/2022 | 40,110 | $108.20 | $4.3M | +27.79% |
Chambers Michael /aldevron/ Director | Buy | 9/14/2022 | 30,106 | $104.67 | $3.2M | +28.13% |
Chambers Michael /aldevron/ Director | Buy | 9/14/2022 | 20,744 | $103.87 | $2.2M | +28.13% |
Wilsey M Kathleen Behrens Director | Buy | 12/19/2022 | 20,000 | $34.92 | $698.4K | +12.06% |
Chambers Michael /aldevron/ Director | Buy | 8/19/2022 | 6,060 | $108.80 | $659.3K | +27.79% |
Chambers Michael /aldevron/ Director | Buy | 9/14/2022 | 6,250 | $105.16 | $657.3K | +28.13% |
Rodino Klapac Louise /sarepta/ |  Sale | 11/17/2022 | 4,211 | $108.52 | $457.0K | +25.35% |
Estepan Ian M Chief Financial Officer | Sale | 3/06/2023 | 1,370 | $157.21 | $215.4K | -11.64% |
Brown Ryan E/acadia/ General Counsel & Senior Vice President | Sale | 3/06/2023 | 1,154 | $157.21 | $181.4K | -11.64% |
Rodino Klapac Louise /sarepta/ | Sale | 3/06/2023 | 1,134 | $157.21 | $178.3K | -11.64% |
Page of 4